MedTrace Logo

The Clinical Comparison of Narafilcon A and Stenfilcon A Contact Lenses

NCT02920970 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 72

Last updated 2019-01-16

Study results available
· View outcomes & findings →

Summary

This study aims to compare the clinical performance and subjective acceptance of the narafilcon A lens with the stenfilcon A lens when used on a daily wear, daily disposable basis.

Conditions

  • Myopia

Interventions

DEVICE

narafilcon A

contact lens

DEVICE

stenfilcon A

contact lens

Sponsors & Collaborators

  • CooperVision, Inc.

    lead INDUSTRY

Principal Investigators

  • Philip Morgan, PhD, FAAO, FBCLA · Eurolens Research, University of Manchester

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-09-01
Primary Completion
2016-12-22
Completion
2017-05-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02920970 on ClinicalTrials.gov